Your browser doesn't support javascript.
loading
Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2.
Fu, Jiewen; Liu, Shuguang; Tan, Qi; Liu, Zhiying; Qian, Jie; Li, Ting; Du, Jiaman; Song, Binghui; Li, Dabing; Zhang, Lianmei; He, Jiayue; Guo, Kan; Zhou, Baixu; Chen, Hanchun; Fu, Shangyi; Liu, Xiaoyan; Cheng, Jingliang; He, Tao; Fu, Junjiang.
Afiliação
  • Fu J; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Liu S; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Tan Q; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Liu Z; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Qian J; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Li T; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Du J; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Song B; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Li D; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Zhang L; Basic Medical School, Southwest Medical University, Luzhou 646000, China.
  • He J; Department of Pathology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an 223300, China.
  • Guo K; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Zhou B; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Chen H; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Fu S; Department of Gynecology and Obstetrics, Guangdong Women and Children Hospital, Guangzhou 511400, China.
  • Liu X; Department of Biochemistry, School of Life Sciences, Central South University, Changsha 410013, China.
  • Cheng J; School of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
  • He T; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
  • Fu J; Key Laboratory of Epigenetics and Oncology, the Research Center for Preclinical Medicine, Southwest Medical University, Luzhou 646000, China.
Molecules ; 27(21)2022 Nov 01.
Article em En | MEDLINE | ID: mdl-36364238
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / COVID-19 / Tratamento Farmacológico da COVID-19 / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Molecules Assunto da revista: BIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / COVID-19 / Tratamento Farmacológico da COVID-19 / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Molecules Assunto da revista: BIOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China